Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: A cost-effectiveness analysis
- Aguilar-Serra, J.
- Gimeno-Ballester, V.
- Pastor-Clerigues, A.
- Milara, J.
- Marti-Bonmati, E.
- Trigo-Vicente, C.
- Alós-Almiñana, M.
- Cortijo, J.
ISSN: 2042-6313, 2042-6305
Argitalpen urtea: 2019
Alea: 8
Zenbakia: 11
Orrialdeak: 853-863
Mota: Artikulua